Augmented hepatic PTEN and reduced systemic FGF21 levels, in turn, perturbed hepatic as well as systemic insulin sensitivity, leading to basal hyperinsulinemia and impaired glucose tolerance. Here, INS is linked to Impaired glucose tolerance.